Ambeed.cn

首页 / 抑制剂/激动剂 / 抗感染 / Antiviral / Germacrone

Germacrone {[allProObj[0].p_purity_real_show]}

货号:A578841 同义名: (E,E)-Germacrone

Germacrone是一种从姜黄中提取的天然产物,具有抗肿瘤活性,能够通过线粒体途径诱导乳腺癌细胞凋亡。

Germacrone 化学结构 CAS号:6902-91-6
Germacrone 化学结构
CAS号:6902-91-6
Germacrone 3D分子结构
CAS号:6902-91-6
Germacrone 化学结构 CAS号:6902-91-6
Germacrone 3D分子结构 CAS号:6902-91-6
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Germacrone 纯度/质量文件 产品仅供科研

货号:A578841 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >

Germacrone 生物活性

描述 Germacrone, a natural product isolated and purified from the rhizoma of Curcuma wenyujin with anti-tumor activity, can inhibit the proliferation of breast cancer cell lines by inducing cell cycle arrest and apoptosis through mitochondria-mediated caspase pathway, and may be a potent chemopreventive drug candidate for liver cancer via regulating the expression of proteins related to G2/M cell cycle and apoptosis, and p53 and oxidative damage may play important roles in the inhibition of human hepatoma cells growth by germacrone.

Germacrone 细胞实验

Cell Line
Concentration Treated Time Description References
Differentiated HepaRG cells 100 µM 1, 6, 12, 24 hours To evaluate the effect of Germacrone on reactive oxygen species (ROS) production in HepaRG cells, results showed that Germacrone significantly increased ROS production at 100 µM. Nutrients. 2020 Jun 8;12(6):1720.
Differentiated HepaRG cells 250 µM 24 hours To evaluate the effect of Germacrone on the viability of HepaRG cells, results showed that Germacrone significantly inhibited cell viability at 250 µM. Nutrients. 2020 Jun 8;12(6):1720.
LO2 cells 10-40 μM 12 hours GER protects hepatocytes by inhibiting APAP-induced mitochondrial ROS release Front Pharmacol. 2021 Oct 5;12:745561.
LX-2 cells 60-120 μM 24 hours GER promotes HSC apoptosis by upregulating cleaved-caspase 3 protein expression and inhibiting anti-apoptotic protein Bcl-2 expression Front Pharmacol. 2021 Oct 5;12:745561.
GES-1 cells 7.89% 24, 48, 72 hours To investigate the effect of Germacrone on the proliferation of GES-1 cells, results showed that high concentrations ( ≥90μg/mL) of zedoary oil killed GES-1 cells. Chin Med. 2013 Jun 28;8:13.
MGC 803 cells 7.89% 24, 48, 72 hours To investigate the effect of Germacrone on the proliferation of MGC 803 cells, results showed that zedoary oil significantly decreased the cell viability of MGC 803 cells. Chin Med. 2013 Jun 28;8:13.
AGS cells 7.89% 24, 48, 72 hours To investigate the effect of Germacrone on the proliferation of AGS cells, results showed that zedoary oil significantly decreased the cell viability of AGS cells. Chin Med. 2013 Jun 28;8:13.
IEC-6 cells 1, 2, 4 μM 24 hours Germacrone significantly upregulated the mRNA expression of HO-1 and NQO1 in IEC-6 cells and significantly increased the mRNA expression of ZO-1 and Occludin to alleviate ethanol-induced intestinal barrier injury. Front Pharmacol. 2022 Sep 26;13:981706.
HepG2 cells 0.5, 1, 2 μM 24 hours Germacrone significantly downregulated the mRNA transcription of NQO1 in HepG2 cells, and GM-H reduced the expression of HO-1, while the protein expression of HO-1 showed a similar trend. Front Pharmacol. 2022 Sep 26;13:981706.

Germacrone 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Sprague-Dawley rats Adjuvant-induced arthritis (AIA) rat model Tail vein injection 8 mg/kg GER Administered on days 16, 18, 20, 22, and 24 Evaluate the therapeutic effect of FA-NPs/GER in AIA rats, results showed that FA-NPs/GER significantly reduced the swelling and inflammation infiltration of the rat’s foot and decreased the levels of pro-inflammatory cytokines (TNF-α, IL-1β). Drug Deliv. 2022 Dec;29(1):692-701.
C57BL/6 mice MCD diet-induced liver fibrosis model Intragastric gavage 25 or 50 mg/kg Once daily for 6 weeks GER ameliorates MCD diet-induced liver fibrosis by inhibiting the TGF-β/Smad signaling pathway Front Pharmacol. 2021 Oct 5;12:745561.

Germacrone 参考文献

[1]An JF, Sun Y, et al. The effects of germacrone on lipopolysaccharide-induced acute lung injury in neonatal rats. Cell Mol Biol (Noisy-le-grand). 2014 Nov 16;60(4):8-12.

[2]Xie XH, Zhao H, et al. Germacrone reverses Adriamycin resistance through cell apoptosis in multidrug-resistant breast cancer cells. Exp Ther Med. 2014 Nov;8(5):1611-1615. Epub 2014 Aug 26.

Germacrone 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.58mL

0.92mL

0.46mL

22.90mL

4.58mL

2.29mL

45.80mL

9.16mL

4.58mL

Germacrone 技术信息

CAS号6902-91-6
分子式C15H22O
分子量 218.33
SMILES Code C/C(C)=C1C/C=C(C)/CC/C=C(C)/CC\1=O
MDL No. MFCD00210050
别名 (E,E)-Germacrone
运输蓝冰
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry, 2-8°C

溶解方案

DMSO: 105 mg/mL(480.91 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
方案 三
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。